Learn, Analyse & Invest
only with
only with
+91
Download Orca
Gujarat Themis Biosyn Ltd.
Guj. Themis Biosyn
Gujarat Themis Biosyn Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹53.67 Cr.
| EX-Date | Purpose |
|---|---|
| 01 05 2021 | Audited Results & Final Dividend |
| 12 08 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results & Interim Dividend |
| 11 02 2022 | Quarterly Results |
| 20 05 2022 | Final Dividend & Audited Results |
| 27 07 2022 | Quarterly Results |
| 07 11 2022 | Quarterly Results |
| 21 11 2022 | Interim Dividend |
| 03 02 2023 | Quarterly Results |
| 13 05 2023 | Audited Results & Stock Split & Final Dividend |
| 10 08 2023 | Quarterly Results |
| 12 08 2023 | Quarterly Results |
| 04 11 2023 | Quarterly Results |
| 10 02 2024 | Quarterly Results & Interim Dividend |
| 25 10 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 20 05 2025 | Final Dividend & Audited Results |
| 10 11 2025 | Quarterly Results |
| 05 02 2026 | Quarterly Results |
| 25 05 2026 | Preferential Issue of shares & Final Dividend & Audited Results |
| 06 06 2026 | Fund Raising Inter alia, to consider and approve the proposals for raising funds by way of issue of equity shares / securities through Qualified Institutions Placement or Preferential Allotment or any other methods / modes or combination thereof. |
| 19 06 2026 | Preferential Issue of shares Inter alia, to evaluate proposal for raising funds through issue of equity shares / securities including Compulsory Convertible Debentures, Optionally Convertible Debentures and Non-Convertible Debentures through preferential issue on a private placement basis or any other manner, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, subject to necessary approvals including approval of the shareholders of the Company and stock exchanges, as may be necessary / applicable. |
| 07 08 2026 | Quarterly Results |
| 01 09 2026 | Preferential Issue of shares |
| 10 09 2026 | Inter alia, to consider and approve:- (1) raising funds through issue of Non-Convertible Debentures by way of Private Placement. |